Who Paid My Doc
Amyvid
Drug Neuroscience
NDC 0002-1200-48
General payments
$334,306
Research payments
$842,771
Through program year 2025, $334,306 in general payments and $842,771 in research payments were reported against Amyvid (Neuroscience).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $113,058 | 6,014 |
| 2024 | General | $221,205 | 11,351 |
| 2024 | Research | $842,771 | 6 |
| 2023 | General | $44 | 2 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 75 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 41 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
17,367 general · 6 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.